1. Home
  2. CURV vs GLUE Comparison

CURV vs GLUE Comparison

Compare CURV & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CURV
  • GLUE
  • Stock Information
  • Founded
  • CURV 2001
  • GLUE 2019
  • Country
  • CURV United States
  • GLUE United States
  • Employees
  • CURV N/A
  • GLUE N/A
  • Industry
  • CURV Clothing/Shoe/Accessory Stores
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CURV Consumer Discretionary
  • GLUE Health Care
  • Exchange
  • CURV Nasdaq
  • GLUE Nasdaq
  • Market Cap
  • CURV 307.0M
  • GLUE 283.6M
  • IPO Year
  • CURV 2021
  • GLUE 2021
  • Fundamental
  • Price
  • CURV $3.03
  • GLUE $5.20
  • Analyst Decision
  • CURV Hold
  • GLUE Buy
  • Analyst Count
  • CURV 4
  • GLUE 2
  • Target Price
  • CURV $5.00
  • GLUE $13.50
  • AVG Volume (30 Days)
  • CURV 1.1M
  • GLUE 415.2K
  • Earning Date
  • CURV 09-03-2025
  • GLUE 08-07-2025
  • Dividend Yield
  • CURV N/A
  • GLUE N/A
  • EPS Growth
  • CURV N/A
  • GLUE N/A
  • EPS
  • CURV 0.09
  • GLUE 0.08
  • Revenue
  • CURV $1,089,931,000.00
  • GLUE $159,487,000.00
  • Revenue This Year
  • CURV N/A
  • GLUE $49.02
  • Revenue Next Year
  • CURV N/A
  • GLUE N/A
  • P/E Ratio
  • CURV $32.92
  • GLUE $66.53
  • Revenue Growth
  • CURV N/A
  • GLUE 14889.38
  • 52 Week Low
  • CURV $2.18
  • GLUE $3.50
  • 52 Week High
  • CURV $9.14
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • CURV 31.60
  • GLUE 64.63
  • Support Level
  • CURV $2.62
  • GLUE $4.42
  • Resistance Level
  • CURV $2.94
  • GLUE $4.85
  • Average True Range (ATR)
  • CURV 0.22
  • GLUE 0.24
  • MACD
  • CURV -0.03
  • GLUE 0.05
  • Stochastic Oscillator
  • CURV 16.08
  • GLUE 81.55

About CURV Torrid Holdings Inc.

Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: